Back to GetFilings.com



 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10–Q

 

ý

 

QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

 

 

 

 

For the quarterly period ended September 25, 2004

 

 

 

 

 

OR

 

 

 

o

 

TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from               to              

 

Commission File No. 0–22384

 

MICRO COMPONENT TECHNOLOGY, INC.

(Exact name of registrant as specified in its charter)

 

Minnesota

 

41–0985960

(State or other jurisdiction of
incorporation or organization)

 

(I.R.S. Employer
Identification No.)

 

 

 

2340 West County Road C, St. Paul, MN 55113-2528

(Address of principal executive offices)

 

 

 

(651) 697–4000

(Registrant’s telephone number)

 

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

 

Yes         ý            No           o

 

Indicate by check mark whether the Registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).

 

Yes         o            No           ý

 

The number of shares outstanding of the Registrant’s Common Stock, as of November 5, 2004 was 25,258,609

 

 



 

MICRO COMPONENT TECHNOLOGY, INC.

FORM 10-Q

 

TABLE OF CONTENTS

 

PART I - FINANCIAL INFORMATION

 

 

 

 

 

ITEM 1. FINANCIAL STATEMENTS

 

 

 

 

 

 

CONSOLIDATED BALANCE SHEETS

 

 

 

 

 

 

 

CONSOLIDATED STATEMENTS OF OPERATIONS

 

 

 

 

 

 

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

 

 

 

 

 

 

 

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

 

 

 

 

 

 

 

ITEM 2.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF RESULTS OF OPERATIONS AND FINANCIAL CONDITION

 

 

 

 

 

ITEM 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

 

 

 

 

ITEM 4. CONTROLS AND PROCEDURES

 

 

 

 

 

 

 

PART II. OTHER INFORMATION

 

 

 

 

 

ITEM 2.

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

 

 

 

 

ITEM 5.

OTHER INFORMATION

 

 

 

 

 

ITEM 6.

EXHIBITS AND REPORTS ON FORM 8-K

 

 

 

 

 

SIGNATURES

 

 

2



 

MICRO COMPONENT TECHNOLOGY, INC.

FORM 10-Q

PART I.  FINANCIAL INFORMATION

ITEM 1.  FINANCIAL STATEMENTS

CONSOLIDATED BALANCE SHEETS

(In thousands, except share and per share data)

(Unaudited)

 

 

 

September 25, 2004

 

December 31, 2003

 

Assets

 

 

 

 

 

Current assets

 

 

 

 

 

Cash and cash equivalents

 

$

420

 

$

1,078

 

Accounts receivable, less allowance for doubtful accounts of $271 and $303, respectively

 

3,084

 

1,539

 

Inventories

 

3,417

 

3,413

 

Other

 

372

 

273

 

Total current assets

 

7,293

 

6,303

 

 

 

 

 

 

 

Property, plant and equipment, net

 

301

 

336

 

Debt issuance costs, net

 

414

 

499

 

Other assets

 

60

 

56

 

 

 

 

 

 

 

Total assets

 

$

8,068

 

$

7,194

 

 

 

 

 

 

 

Liabilities and Stockholders’ Deficit

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Line of credit

 

$

1,084

 

$

348

 

Current portion of long-term convertible note

 

800

 

 

Accounts payable

 

1,497

 

1,518

 

Accrued compensation

 

571

 

469

 

Accrued interest

 

108

 

370

 

Accrued warranty

 

117

 

181

 

Customer prepayments and unearned service revenue

 

359

 

1,410

 

Deferred revenue in excess of costs incurred

 

 

16

 

Other accrued liabilities

 

72

 

373

 

Total current liabilities

 

4,608

 

4,685

 

 

 

 

 

 

 

Long-term portion of accounts payable

 

 

195

 

Long-term convertible note

 

901

 

 

10% senior subordinated convertible note

 

3,630

 

7,340

 

 

 

 

 

 

 

Stockholders’ deficit:

 

 

 

 

 

Preferred stock, $.01 par value, 1,000,000 authorized, none issued and outstanding

 

 

 

Common stock, $.01 par value, 40,000,000 authorized, 25,258,609 and 21,145,300 issued, respectively

 

253

 

212

 

Additional paid-in capital

 

96,873

 

92,668

 

Cumulative other comprehensive loss

 

(69

)

(69

)

Accumulated deficit

 

(98,128

)

(97,837

)

Total stockholders’ deficit

 

(1,071

)

(5,026

)

Total liabilities and stockholders’ deficit

 

$

8,068

 

$

7,194

 

 

See notes to unaudited condensed consolidated financial statements

 

3



 

MICRO COMPONENT TECHNOLOGY, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share data)

(Unaudited)

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

 

Sept. 25, 2003

 

Sept. 27, 2004

 

Sept. 25, 2003

 

Sept. 27, 2004

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

3,859

 

$

2,852

 

$

12,351

 

$

7,385

 

Cost of sales

 

1,902

 

1,581

 

5,892

 

4,505

 

 

 

 

 

 

 

 

 

 

 

Gross profit

 

1,957

 

1,271

 

6,459

 

2,880